Article
nderstanding both benefits and adverse effects of AHAs will give optimumoutcomes on aging skin
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Peter Lio, MD, Advocates for Personalized Pediatric Dermatology
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Can Colloidal Oat Emollients Be Used to Treat Pediatric Atopic Dermatitis?
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
New Qtorin Rapamycin Data Featured at World Congress of Pediatric Dermatology
Icotrokinra Demonstrates Efficacy in Adolescents and Adults With Moderate to Severe Psoriasis in ICONIC-LEAD Phase 3 Study
Daily Derm Times: May 6, 2025
Topical Steroid Withdrawal: Uncovering Neuroinflammatory Mechanisms
Upadacitinib Shows Promise in Reducing Cardiovascular and Thrombotic Risks in Atopic Dermatitis Patients
Clinical Trial Validates Delgocitinib’s HRQoL Benefits